Scott Coleman
Corporate Officer/Principal en XILIO THERAPEUTICS, INC. .
Cargos activos de Scott Coleman
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| XILIO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2022 | - |
Historial de carrera de Scott Coleman
Antiguos cargos conocidos de Scott Coleman.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ACCELERON PHARMA INC. | Corporate Officer/Principal | - | - |
Formación de Scott Coleman.
| North Carolina State University | Doctorate Degree |
| Northeastern University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| XILIO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Scott Coleman
- Experiencia
